Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The Benefits Of A Corporate Integrity Agreement: An Industry Perspective

Executive Summary

Novo exec says CIAs can help spur culture change to improve sales rep compliance; cooperation can also help avoid corporate integrity agreements in future settlements.

You may also be interested in...



Novo's Victoza REMS Settlement Opens Another Legal Door For Off-Label Promotion Cases

US government alleged sales reps gave information to physicians to create a false or misleading impression that Victoza's boxed warning and REMS messages about medullary thyroid cancer were 'erroneous, irrelevant or unimportant.' Novo's $59m settlement includes resolution of whistleblower lawsuits alleging off-label marketing.

Novo Nordisk Settles Over US Federal Investigation Of Marketing Practices

Novo Nordisk has settled with the US Federal government over claims it did not comply with communicating safety information on its diabetes drug Victoza.

Pharma And The CIA

Three years ago, nine of top 10 and 12 of the top 20 pharma companies were bound by five-year pledges signed with the US Department of Health & Human Services' Office of Inspector General following cases investigating misconduct. Not an ideal state of affairs for an industry desperate to improve its reputation.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS122594

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel